Thrombectomy Devices Market - Size, Share, Trends, and Forecast to 2026

Thrombectomy Devices Market - Size, Share, Trends, and Forecast to 2026

Thrombectomy procedures allow surgeons to use a mechanical device to break up or remove the blood clot and restore normal blood flow. It helps neurosurgeons to improve patients’ health, especially those experiencing a large artery stroke. Thrombectomy is widely used in developed economies, due to high number of stroke incidences and increased spending in healthcare.

Market Dynamics

Increasing incidences of deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke are the major factors fuelling high demand for thrombectomy devices. Pulmonary embolism (PE) is the most serious and life-threating complication caused due to thromboembolism. Inappropriate treatment of acute DVT can result in thrombus organization and post-thrombosis syndrome (PTS) in patients, seriously affecting their quality of life. According to University of California, about 10-15% of stroke patients are candidates for thrombectomy, and about 4.7% of patients underwent the treatment in 2015, up from 1.5% in 2009.

Despite high demand and applicability of thrombectomy devices, it also poses certain limitations, which can restrain growth of the market during the forecast period. For instance, side effects of thrombectomy include intracerebral hemorrhage, subarachnoid hemorrhage, device related injury to the vessel wall, and fragmentation of the target thrombus.

Key features of the study:

• This report provides in-depth analysis of the thrombectomy devices market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%) for the forecast period: 2018 – 2026, considering 2017 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global thrombectomy devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Applied Medical, Argon Medical Devices, Inc., Boston Scientific Corporation, BTG International, Capture Vascular, Claret Medical, Control Medical Technology, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic PLC, Merit Medical Systems, Inc., Minnetronix, Inc., Nexgen Medical Systems, Inc., Natec Medical Ltd., Penumbra, Inc., Phenox GmbH, Stentys SA, Spectranetics Corporation, Straub Medical AG, Stryker Corporation, Terumo Corporation, and Teleflex Incorporated
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological upgradation, market expansion, and marketing tactics
• The global thrombectomy devices market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for thrombectomy devices market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

• Global Thrombectomy Devices Market, By Product Type:
• Mechanical Thrombectomy Devices
• Aspiration Thrombectomy Devices
• Hydrodynamic Thrombectomy Devices
• Ultrasonic Thrombectomy Devices
• Global Thrombectomy Devices Market, By Application:
• Neurovascular
• Cardiovascular
• Peripheral Vascular
• Global Thrombectomy Devices Market, By End User:
• Hospitals
• Ambulatory Surgical Centers
• Research Laboratories and Academic Institutes
• Global Thrombectomy Devices Market, By Region:
• North America
• By Country:
• U.S.
• Canada
• By Product Type:
• Mechanical Thrombectomy Devices
• Aspiration Thrombectomy Devices
• Hydrodynamic Thrombectomy Devices
• Ultrasonic Thrombectomy Devices
• By Application:
• Neurovascular
• Cardiovascular
• Peripheral Vascular
• By End User:
• Hospitals
• Ambulatory Surgical Centers
• Research Laboratories and Academic Institutes
• Europe
• By Country:
• U.K.
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe
• By Product Type:
• Mechanical Thrombectomy Devices
• Aspiration Thrombectomy Devices
• Hydrodynamic Thrombectomy Devices
• Ultrasonic Thrombectomy Devices
• By Application:
• Neurovascular
• Cardiovascular
• Peripheral Vascular
• By End User:
• Hospital
• Ambulatory Surgical Centers
• Research Laboratories and Academic Institutes
• Asia Pacific
• By Country:
• Australia
• India
• China
• Japan
• ASEAN
• South Korea
• Rest of Asia Pacific
• By Product Type:
• Mechanical Thrombectomy Devices
• Aspiration Thrombectomy Devices
• Hydrodynamic Thrombectomy Devices
• Ultrasonic Thrombectomy Devices
• By Application:
• Neurovascular
• Cardiovascular
• Peripheral Vascular
• By End User:
• Hospitals
• Ambulatory Surgical Centers
• Research Laboratories and Academic Institutes
• Latin America
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• By Product Type:
• Mechanical Thrombectomy Devices
• Aspiration Thrombectomy Devices
• Hydrodynamic Thrombectomy Devices
• Ultrasonic Thrombectomy Devices
• By Application:
• Neurovascular
• Cardiovascular
• Peripheral Vascular
• By End User:
• Hospitals
• Ambulatory Surgical Centers
• Research Laboratories and Academic Institutes
• Middle East
• By Country:
• GCC
• Israel
• Rest of Middle East
• By Product Type:
• Mechanical Thrombectomy Devices
• Aspiration Thrombectomy Devices
• Hydrodynamic Thrombectomy Devices
• Ultrasonic Thrombectomy Devices
• By Application:
• Neurovascular
• Cardiovascular
• Peripheral Vascular
• By End User:
• Hospitals
• Ambulatory Surgical Centers
• Research Laboratories and Academic Institutes
• Africa
• By Country:
• South Africa
• Central Africa
• North Africa
• By Product Type:
• Mechanical Thrombectomy Devices
• Aspiration Thrombectomy Devices
• Hydrodynamic Thrombectomy Devices
• Ultrasonic Thrombectomy Devices
• By Application:
• Neurovascular
• Cardiovascular
• Peripheral Vascular
• By End User:
• Hospitals
• Ambulatory Surgical Centers
• Research Laboratories and Academic Institutes
• Company Profiles
• Applied Medical*
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Highlights
• Strategies
• Argon Medical Devices, Inc.
• Boston Scientific Corporation
• Boston Scientific Corporation
• Capture Vascular
• Claret Medical
• Control Medical Technology
• Edwards Lifesciences Corporation
• Johnson & Johnson
• Medtronic PLC
• Merit Medical Systems, Inc.
• Minnetronix, Inc.
• Nexgen Medical Systems, Inc.
• Natec Medical Ltd.
• Penumbra, Inc.
• Phenox GmbH
• Stentys SA
• Spectranetics Corporation
• Straub Medical AG
• Stryker Corporation
• Terumo Corporation
• Teleflex Incorporated

“*” marked represents similar segmentation in other categories in the respective section.